1-3 of 3
Jordan Briggs
Close
Sort by
Journal Articles

Multiple Doses of Cnty-101, an iPSC-Derived Allogeneic CD19 Targeting CAR-NK Product, Are Safe and Result in Tumor Microenvironment Changes Associated with Response: A Case Study

Indu Ramachandran, Sarah Rothman, Mariano Clausi, Kile Mcfadden, Brenda Salantes, Gloria Jih, Thomas Brigman, Sam Kelly, Matthew S Hall, Stephanie Yee, Iphigenia Koumenis, Poulomee Das, Jordan Briggs, Tori Braun, Ying Yuan, Elizabeth Devlin, Adrienne Farid, Nikolaus S. Trede, Tamara K. Moyo, Tahir Latif, Krish Patel
Journal: Blood
Blood (2023) 142 (Supplement 1): 1654.
https://doi.org/10.1182/blood-2023-182313
Published: 2023
Journal Articles

Initial Efficacy and Safety of Acalabrutinib Plus RICE in Transplant Eligible Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Neil Bailey, Tori Braun, Megumi Bailey, Tenzin Tsomo, Jennie Szeto, Sandra Benitez Kruidenier, Vanessa Dunleavy, Joanna Fesler, Gayle Funk, Sonia Glennie, Judson Hall, Julia Parker, Daniel Egan, Raya Mawad, Carol A Dean, Suzan Sullivan, Chia Lu, Heidi Hohmann, Jordan Briggs, Krish Patel
Journal: Blood
Blood (2022) 140 (Supplement 1): 3765–3766.
https://doi.org/10.1182/blood-2022-164823
Published: 2022
Journal Articles

Initial Safety Results from a Phase II Study of Acalabrutinib Plus RICE Followed By Autologous Hematopoietic Cell Transplantation and/or Acalabrutinib Maintenance Therapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Neil Bailey, Tenzin Tsomo, Tori Braun, Jennie Szeto, William I. Bensinger, Daniel Egan, Raya Mawad, Livia Hegerova, Gayle Funk, Joanna Fesler, Sonia Glennie, Judson Hall, Vanessa Dunleavy, Heidi Hohmann, Jordan Briggs, Joshua Mark, Megumi Bailey, John M. Pagel, Krish Patel
Journal: Blood
Blood (2021) 138 (Supplement 1): 4554.
https://doi.org/10.1182/blood-2021-148505
Published: 2021